Basic Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2183-2194
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2183
Table 1 Immunohistochemical expression of TIRM55 in gastric cancer and normal tissues
Tissue
N
High expression
Low expression
P value
Gastric cancer914051< 0.001
Normal 91389
Table 2 Association between TRIM55 expression and clinicopathological characteristics
VariablesNo. of caseTRIM55 expression
χ2
P value
High (n = 40)
Low (n = 51)
Gender0.2840.594
Male612833
Female301218
Age (n) 0.2160.642
≤ 65482028
> 65432023
Tumor location0.0080.928
Proximal1468
Dismatal773443
pT stage6.2320.013
T1 + T2431330
T3 + T4482721
Lymph node metastasis5.5060.019
Negative491633
Positive422418
TNM stage5.1460.023
Ⅰ + Ⅱ531835
382216
Lauren histotype3.3660.067
Intestinal472522
Diffuse441529
Table 3 Univariate and multivariate Cox regression models for estimating the overall survival
Variable
Univariate analysis
Multivariate analysis
HR
95%CI
P value
HR
95%CI
P value
Gender0.790.12–1.380.463
Age0.560.38–1.500.517
Tumor location1.670.53–2.270.770
pT stage0.850.61–0.930.041
Lymph node metastasis3.292.07–5.440.0052.641.35–3.080.021
TNM stage2.181.32–2.890.0161.201.06–1.880.028
Lauren histotype1.450.39–2.460.433
TRIM552.371.53–3.810.0281.481.17–1.920.035